Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQYZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,881
Award facts
- Contract value 100% obligated
- $11,880.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30 units, with a contract ceiling value of $11,880.95. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical product deliveries through the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX prime contract vehicle enables AmerisourceBergen to provide comprehensive global pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the Department of Defense's medical logistics infrastructure.
Quick answers
Who was awarded contract SPE2DB25FQYZY?
SPE2DB25FQYZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FQYZY worth?
The government has obligated $11,881 on SPE2DB25FQYZY.
Is contract SPE2DB25FQYZY an order under another contract?
Yes. SPE2DB25FQYZY is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQYZY competed?
The extent of competition for SPE2DB25FQYZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award